The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection

E-ISSN： 1875-533x|18|4|497-512

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.4, 2011-02, pp. : 497-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus

By Chong Benjamin F Mohan Chandra

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 10, 2009-10 ,pp. : 1147-1153

Informa Healthcare

Access to resources Recommend Favorite

CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization

Current Pharmaceutical Design, Vol. 16, Iss. 35, 2010-12 ,pp. : 3903-3920

Bentham Science Publishers

Access to resources Recommend Favorite

The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1284-1290

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis

By Tamamura Hirokazu Fujii Nobutaka

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1267-1282

Informa Healthcare

Access to resources Recommend Favorite

Chemokines and their Receptors as Therapeutic Targets: The Role of the SDF-1 / CXCR4 Axis

Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. : 1245-1259

Bentham Science Publishers

Access to resources Recommend Favorite